Martín Ocampo-Posada, Departamento de Medicina Interna, Universidad Libre, Cali; Grupo Interinstitucional Medicina Interna (GIMI 1), Universidad Libre, Cali; Departamento de Medicina Interna, Clínica Versalles, Cali; Facultad de Salud, Programa de Medicina, Pontificia Universidad Javeriana, Cali; Grupo de Investigación en Ciencias Básicas y Clínicas de la Salud, Universidad Javeriana, Cali; Colombia
David Aristizábal-Colorado, Departamento de Medicina Interna, Universidad Libre, Cali; Grupo Interinstitucional Medicina Interna (GIMI 1), Universidad Libre, Cali; Colombia
Wilfredo A. Rivera-Martínez, Departamento de Medicina Interna, Universidad Libre, Cali; Grupo Interinstitucional Medicina Interna (GIMI 1), Universidad Libre, Cali;; Departamento de Endocrinología, Universidad de Antioquia, Medellín;
Luis A. Valderrama-Terán, Facultad de Salud, Programa de Medicina, Pontificia Universidad Javeriana, Cali, Colombia
Santiago Sierra-Castillo, Departamento de Epidemiología, Universidad CES, Medellín. Colombia
Andrés Mejía, Departamento de Medicina Interna, Universidad Libre, Cali; Grupo Interinstitucional Medicina Interna (GIMI 1), Universidad Libre, Cali, Colombia
Leopoldo Garcés-Villabón, Departamento de Medicina Interna, Universidad Libre, Cali;; Departamento de Medicina Interna, Clínica Versalles, Cali; Colombia
Óscar M. Pinillos-Sénior, Departamento de Medicina Interna, Clínica Versalles, Cali; Facultad de Salud, Programa de Medicina, Pontificia Universidad Javeriana, Cali; Colombia
Introduction: Acutely decompensated heart failure (ADHF) consists of the rapid onset or change of signs and symptoms of heart failure that require medical attention and generally lead to hospitalization of the patient. A descriptive registry of patients with acutely decompensated heart failure is presented, taken in a single center, collected from 2020 to 2022. Objective: Register patients treated for acutely decompensated heart failure with clinical and paraclinical characteristics, pharmacological strategies, and strong outcomes during care. Methods: It is an ambispective observational registry of descriptive characteristics in patients treated with acutely decompensated heart failure from 2020-2022. The population variables were summarized using descriptive statistics. Results: 508 patients were included: 51.2% men, average age 71 years. The main comorbidity was arterial hypertension (73.6%). The main cause of heart failure was ischemic (46.9%). On admission, NYHA III (29.3%) and Stevenson B (74.6%) categories were the most prevalent. 41.7% of patients received beta blockers, 33.7% diuretics, 20.6% MRAs, 45.7% ARA-II or ACEIs, 18.11% SGLT2i, and 8.9% ARNI. The average hospital stay was 11 days and mortality was 9.6%. Conclusion: The MALEOS registry is to our knowledge the largest collection of patients with acutely decompensated heart failure from a single center in the suroccident of the country. The presence of a greater proportion of patients with preserved LVEF and a low number of patients with dyslipidemia, atrial fibrillation, renal failure and diabetes mellitus is highlighted.
Keywords: Heart failure. Hospitalization. Mortality. Treatment.
